Sun Pharma Raises Offer Price To Fully Acquire Taro Pharmaceutical
Sun Pharmaceutical Industries Ltd. has revised its offer price to acquire all the outstanding shares of its Israel-based arm, Taro Pharmaceutical Industries Ltd.
The offer price has been raised to $43 per share versus $38 per share earlier, a rise of 13%, according to an exchange filing on Tuesday.
On May 26, Sun Pharma expressed its interest to increase its stake in Taro to 100%. It currently holds a 78.48% stake in Taro. The company engaged in multiple rounds of price negotiations with a special committee of Taro's board of directors regarding the proposal.
The negotiations resulted in the company communicating to the special committee the updated terms, pursuant to which it proposed to acquire all of the outstanding shares of Taro's ordinary shares, it said.
Negotiations regarding definitive terms and agreements for the revised proposal are ongoing, and no assurances can be given that a definitive agreement will be reached, according to Sun Pharma.
Shares of Sun Pharma were trading 1.41% lower at Rs 1,223.85 apiece on the NSE compared to a 0.09% decline in the benchmark NSE Nifty 50 at 12.49 p.m.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
